Skip to content

It looks like we may have content for your preferred language. Would you like to view this page in English?

Three Loeb Partners Recognized in the 2022 LMG Life Sciences Rankings

Loeb & Loeb is pleased to announce that Food & Drug Administration partner Jim Czaban, Mitch Nussbaum, vice chair of Loeb & Loeb and co-chair of the firm’s Capital Markets & Corporate department, and Mark Waddell, co-chair of the Life Sciences practice and chair of the Patent Litigation & Counseling practice, were recognized in the 2022 edition of the LMG Life Sciences rankings, a definitive guide to lawyers and law firms that specialize in the life sciences industry.

The rankings highlight firms and lawyers that specialize in four main practice areas: regulatory, intellectual property, financial and corporate, and non-IP litigation and enforcement.

Specifically, Jim was recognized in the FDA: Medical Device and FDA: Pharmaceutical categories, while Mitch was recognized in the Corporate category and Mark was recognized in the Patent Strategy & Management category.

For more information, please visit LMG Life Sciences’ website.